hypersensitivity vasculitis: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
902 |
4. Check minimum number of eventsNone |
902 |
5. Include endpointsNone |
902 |
6. Filter based on genotype QC (FinnGen only) |
870 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified vasculitis limited to skin
based on the number of shared cases.
Similar with more cases:
- Vasculitis limited to skin, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5748 | 3379 | 2331 |
| Only index persons | 5105 | 3007 | 2098 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.07 |
| Only index persons | 0.10 | 0.11 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 64.72 | 66.92 | 61.51 |
| Only index persons | 63.26 | 65.05 | 60.70 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 870 | 497 | 373 |
| Unadjusted period prevalence (%) | 0.17 | 0.18 | 0.17 |
| Median age at first event (years) | 62.37 | 61.01 | 64.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 902
- Matched controls
- 9020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
77.1
307.7
199
33
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
26.9
307.7
476
360
L95.8
ICD-10 Finland
Other vasculitis limited to skin
2267.7
307.7
389
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
7961.5
307.7
657
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
61.9
194.8
109
20
S97
ICPC
Chronic ulcer skin
11.6
182.0
211
231
H02AB06
ATC
prednisolone; systemic
9.5
179.5
751
3108
TQW80
NOMESCO Finland
Local dermatologic skincare
24.5
176.0
129
61
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
13.4
166.0
170
154
D69.0
ICD-10 Finland
Allergic purpura
202.7
149.8
152
9
L04AX01
ATC
azathioprine; systemic
11.6
130.5
145
147
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
27.3
128.1
89
36
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
18.3
120.9
100
61
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.0
115.7
347
994
A46
ICD-10 Finland
Erysipelas
5.2
105.8
279
713
D07AC01
ATC
betamethasone; topical
4.2
101.2
515
2151
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.0
95.2
259
674
J04BA02
ATC
dapsone; oral
112.3
84.7
91
9
D07AD01
ATC
clobetasol; topical
4.5
84.4
267
776
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
47.0
83.0
49
11
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.6
77.9
479
2169
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
6.0
74.8
146
280
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
11.0
73.3
81
80
J01FF01
ATC
clindamycin; systemic
3.4
69.4
376
1549
E0000UV, ,
ATC
3.3
67.1
509
2553
L04AX03
ATC
methotrexate; systemic
4.6
63.2
173
442
L04AA06
ATC
mycophenolic acid; systemic
14.3
62.7
58
43
L95.0
ICD-10 Finland
Livedoid vasculitis
+∞
61.1
58
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.1
58.8
190
549
XQ848
NOMESCO Finland
Dermatological photography
8.8
56.7
74
91
ZZA00
NOMESCO Finland
Split skin graft
8.8
56.7
74
91
L50.9
ICD-10 Finland
Urticaria, unspecified
7.2
56.1
87
131
C03CA01
ATC
furosemide; systemic
3.0
55.8
410
1965
P01BA02
ATC
hydroxychloroquine; oral
4.5
52.7
144
365
D07AB08
ATC
desonide; topical
4.0
52.7
174
508
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
51.7
184
566
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
49.9
544
3155
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.3
49.1
143
380
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
6.0
49.1
92
168
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
46.2
197
679
NHQ40
NOMESCO Finland
Amputation of toe
16.3
45.4
39
25
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.1
44.0
134
367
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.6
43.7
113
273
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.6
42.6
165
533
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
8.9
42.5
54
64
L04AA01
ATC
[U] ciclosporin
12.3
39.6
40
34
S18
ICPC
Laceration/cut
2.5
39.5
499
2987
M04AA01
ATC
allopurinol; systemic
3.2
39.3
183
661
L50.8
ICD-10 Finland
Other urticaria
9.3
38.4
47
53
D09AB01
ATC
zinc bandage without supplements; topical
9.8
37.4
44
47
E000001, ,
ATC
2.8
37.0
241
1046
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
37.0
345
1785
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
11.0
36.9
40
38
N02AX02
ATC
tramadol; systemic, rectal
2.4
36.9
474
2832
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.2
36.9
106
277
A02BC02
ATC
pantoprazole; systemic
2.7
36.6
687
4868
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.3
35.3
153
527
H02AB09
ATC
hydrocortisone; systemic
7.0
35.2
55
83
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
181.8
34.0
35
*
R60.0
ICD-10 Finland
Localized oedema
3.1
33.9
168
626
L01BA01
ATC
methotrexate; systemic
5.4
32.5
66
129
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
31.8
144
508
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
31.4
30
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.0
31.3
165
635
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.6
31.2
77
178
J01DB01
ATC
cefalexin; oral
3.3
31.1
796
6283
H02AB07
ATC
prednisone; oral
2.8
31.0
179
723
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
30.8
192
807
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
37.0
30.8
39
11
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.5
30.3
44
61
J01MA02
ATC
ciprofloxacin; systemic
2.2
29.8
411
2464
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
29.7
287
1482
L04AD01
ATC
ciclosporin; systemic
8.2
29.6
40
51
S76
ICPC
Skin infection other
4.2
29.4
83
213
D07AC13
ATC
mometasone; topical
2.3
28.9
312
1686
SPAT1151
SPAT
Treatment of major wounds
11.0
28.8
31
29
N02AA05
ATC
oxycodone; systemic
2.5
28.7
222
1034
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
28.7
186
795
L03.9
ICD-10 Finland
Cellulitis, unspecified
8.1
28.7
39
50
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
10.3
28.4
32
32
M13.9
ICD-10 Finland
Arthritis, unspecified
3.5
28.0
104
323
N18.8
ICD-10 Finland
Other chronic renal failure
6.6
28.0
46
73
R50.9
ICD-10 Finland
Fever, unspecified
2.7
27.6
179
765
D02AX
ATC
Other emollients and protectives
5.8
27.4
51
92
S29
ICPC
Skin symptom/complaint other
2.5
27.2
216
1017
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
42.7
26.9
33
8
B01AA03
ATC
warfarin; systemic
2.4
26.8
229
1113
M30.0
ICD-10 Finland
Polyarteritis nodosa
99.8
26.8
29
*
J01CF05
ATC
flucloxacillin; systemic
3.8
26.6
87
248
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.8
26.5
156
633
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
26.3
61
134
QDB10, ,
SPAT
6.8
25.7
41
63
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
9.4
25.7
31
34
I50.0
ICD-10 Finland
Congestive heart failure
3.2
25.7
111
379
WZC30
NOMESCO Finland
Teaching
2.5
25.7
185
830
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
29.4
25.5
34
12
A10AB05
ATC
insulin aspart; parenteral
3.3
24.5
102
340
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
24.4
117
424
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
24.3
89
274
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
5.1
24.2
52
107
SPAT1211
SPAT
Application of soft bandage
3.1
24.0
112
399
ZXE00
NOMESCO Finland
One hour or less
2.1
24.0
392
2453
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
23.7
84
253
C03DA01
ATC
spironolactone; oral
2.6
23.7
157
675
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.4
23.6
91
289
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.7
23.6
38
59
L89
ICD-10 Finland
Decubitus ulcer and pressure area
31.0
22.9
30
10
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
22.8
91
295
J01MA12
ATC
levofloxacin; systemic
2.3
22.5
209
1046
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.9
22.2
50
107
A02BC01
ATC
omeprazole; systemic
2.1
22.0
286
1633
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
22.0
75
220
Z3231
NOMESCO Finland
Registered nurse
2.1
21.9
283
1613
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.3
21.6
44
86
R06.0
ICD-10 Finland
Dyspnoea
2.1
21.2
290
1685
ZXD05
NOMESCO Finland
Urgent procedure
2.0
21.0
304
1802
E000003, ,
ATC
3.9
20.9
64
174
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
20.9
90
306
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.0
20.8
61
161
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.5
20.6
52
122
R06AE09
ATC
levocetirizine; oral
2.5
20.6
152
685
WX213
NOMESCO Finland
Lower leg blockade
26.2
20.5
28
11
L52
ICD-10 Finland
Erythema nodosum
20.6
20.5
30
15
A10AC01
ATC
insulin (human); parenteral
3.0
20.4
97
349
B01AB05
ATC
enoxaparin; parenteral
2.0
20.4
326
1997
N03AX16
ATC
[U] pregabalin
2.1
20.3
241
1324
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.7
20.3
48
107
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
20.2
78
248
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.4
20.1
74
228
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
19.3
20.1
30
16
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
24.0
20.0
28
12
XF600
NOMESCO Finland
Bloodpressure measurement
3.2
20.0
82
270
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
19.8
201
1037
L81.7
ICD-10 Finland
Pigmented purpuric dermatosis
107.4
19.6
21
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.8
19.5
102
387
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
19.4
152
702
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
19.3
230
1263
UJF32
NOMESCO Finland
Coloscopy
2.0
19.3
269
1565
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
19.2
354
2265
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
19.0
186
944
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
19.0
181
910
M05BA04
ATC
alendronic acid; oral
2.7
18.9
113
459
N03AX12
ATC
[U] gabapentin; oral
2.2
18.9
181
911
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
18.8
18
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.1
18.6
240
1354
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
18.1
96
366
ZY010
NOMESCO Finland
Hospital outpatient
3.5
18.1
64
192
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.4
18.1
36
69
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
18.0
124
539
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.0
17.9
52
136
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
68.0
17.8
20
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
17.2
288
1771
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.9
17.2
31
54
SPAT1260
SPAT
Consultation of another employee
2.1
17.2
183
958
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.6
17.1
58
169
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
17.0
46
114
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
16.9
95
374
L17
ICPC
Foot/toe symptom/complaint
1.9
16.8
279
1709
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
16.7
50
134
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
91.8
16.6
18
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
16.5
70
235
R23.3
ICD-10 Finland
Spontaneous ecchymoses
5.1
16.5
35
71
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
16.5
142
681
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
16.5
53
149
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
6.2
16.5
28
46
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.8
16.2
37
80
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
16.2
101
418
205
Kela drug reimbursment
Chronic hypertension
1.9
16.1
274
1688
D07BC01
ATC
betamethasone and antiseptics; topical
2.4
16.1
124
567
C07AB07
ATC
bisoprolol; oral
1.8
16.0
474
3457
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.4
15.7
31
59
L30.3
ICD-10 Finland
Infective dermatitis
3.9
15.4
46
123
J01MA14
ATC
moxifloxacin; systemic
2.5
15.3
99
417
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
15.3
410
2892
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
15.2
120
554
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
45.8
15.1
18
*
L28
ICPC
Limited function/disability (L)
2.0
15.1
185
1017
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
15.0
238
1428
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.5
15.0
29
54
E000006, ,
ATC
2.8
15.0
79
300
M10.9
ICD-10 Finland
Gout, unspecified
2.8
15.0
79
300
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
15.0
54
164
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
14.9
89
360
R06AE07
ATC
cetirizine; oral
1.8
14.9
391
2733
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.0
14.8
32
66
ZX120
NOMESCO Finland
Intravenous
2.5
14.8
103
449
B01AB04
ATC
dalteparin; parenteral
3.1
14.8
64
218
SPAT1262
SPAT
Handing over of treatment supplies
2.0
14.7
178
974
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
15.7
14.5
23
15
R06AX27
ATC
desloratadine; oral
1.9
14.4
252
1559
JN4AD
NOMESCO Finland
Body CT examination
2.4
14.3
106
475
R03DC03
ATC
montelukast; oral
2.1
14.3
162
864
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.3
14.2
37
89
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.8
14.2
43
116
A12AA04
ATC
calcium carbonate; oral
6.5
14.2
23
36
D03BA02
ATC
collagenase; topical
43.2
14.1
17
*
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
14.0
65
230
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
14.0
105
474
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.1
13.9
24
40
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
13.8
36
87
B01AB10
ATC
tinzaparin; parenteral
2.3
13.8
109
503
B35.3
ICD-10 Finland
Tinea pedis
3.3
13.7
52
163
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.2
13.7
28
55
Z2446
NOMESCO Finland
Social worker
2.7
13.7
74
285
TK800
NOMESCO Finland
Hemodialysis
5.0
13.6
29
59
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.0
13.4
29
60
L50
ICD-10 Finland
Urticaria
5.4
13.3
26
49
M79.6
ICD-10 Finland
Pain in limb
1.7
13.3
380
2698
A28
ICPC
Limited function/disability NOS
1.9
13.2
181
1030
ZX112
NOMESCO Finland
Subcutaneous
4.2
13.1
35
86
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
13.1
237
1475
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
13.1
460
3446
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
13.0
374
2657
L01AA01
ATC
cyclophosphamide; systemic
19.4
12.9
19
10
I50.1
ICD-10 Finland
Left ventricular failure
2.9
12.9
61
218
G47.3
ICD-10 Finland
Sleep apnoea
1.9
12.8
210
1266
A08
ICPC
Swelling
2.8
12.7
65
243
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.5
12.7
81
339
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
12.7
113
548
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.4
12.6
96
435
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.8
12.6
64
238
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
32.5
12.6
16
5
L50.3
ICD-10 Finland
Dermatographic urticaria
4.9
12.4
27
56
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
12.3
83
356
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
12.3
102
480
M79.3
ICD-10 Finland
Panniculitis, unspecified
38.1
12.2
15
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
12.2
211
1292
C08DB01
ATC
diltiazem; oral
2.8
12.1
64
243
H02AB04
ATC
methylprednisolone; systemic
2.0
12.1
138
735
A10AE04
ATC
insulin glargine; parenteral
2.2
12.0
102
485
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
12.0
175
1016
E000002, ,
ATC
2.2
11.9
103
493
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
47.3
11.9
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
11.8
237
1514
Z71.8
ICD-10 Finland
Other specified counselling
1.7
11.8
269
1784
C08CA05
ATC
nifedipine; systemic
2.7
11.8
67
265
344
Kela drug reimbursment
Omalizumab
65.8
11.6
13
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
11.6
554
4433
Z2221
NOMESCO Finland
Medical doctor
1.7
11.6
249
1623
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
10.2
11.5
22
22
B01AF02
ATC
apixaban; oral
2.0
11.5
131
697
L84
ICD-10 Finland
Corns and callosities
3.8
11.5
35
95
M05.2
ICD-10 Finland
Rheumatoid vasculitis
+∞
11.5
11
*
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
11.5
11
*
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.5
11.4
22
41
N02BE01
ATC
paracetamol; systemic, rectal
2.1
11.4
799
7106
R4180
NOMESCO Finland
Podiatric therapy
8.5
11.3
24
29
SPAT1263
SPAT
Sampling
1.6
11.3
374
2725
D02AE01
ATC
carbamide; topical
2.6
11.3
67
270
TGC00
NOMESCO Finland
Bronchial lavation
3.7
11.3
36
101
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
11.3
69
283
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
20.3
11.2
16
8
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
11.1
101
493
S91.3
ICD-10 Finland
Open wound of other parts of foot
4.0
11.1
31
79
L14
ICPC
Leg/thigh symptom/complaint
2.3
11.1
86
393
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
11.0
177
1057
XQ902
NOMESCO Finland
Other photography
14.1
11.0
18
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.0
362
2632
A07AA09
ATC
vancomycin; oral
5.5
10.9
21
39
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
10.9
114
588
A06AD11
ATC
lactulose; oral
1.9
10.8
144
808
Z3226
NOMESCO Finland
Physiotherapist
1.8
10.8
171
1015
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
10.8
84
384
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.4
10.8
38
114
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
28.4
10.7
14
5
A10AE05
ATC
insulin detemir; parenteral
2.7
10.7
60
235
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
21.8
10.7
15
7
N19
ICD-10 Finland
Unspecified kidney failure
3.0
10.6
47
162
R03DX05
ATC
omalizumab; parenteral
60.7
10.6
12
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
10.6
69
291
I73.0
ICD-10 Finland
Raynaud syndrome
5.1
10.6
22
44
L30.0
ICD-10 Finland
Nummular dermatitis
3.2
10.5
41
131
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.0
10.5
47
163
NFQ20
NOMESCO Finland
Amputation of femur
14.4
10.5
17
12
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
10.5
259
1745
R03BB04
ATC
tiotropium bromide; inhalant
2.1
10.4
104
526
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
10.4
10
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
10.4
156
911
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
10.4
246
1640
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
10.3
105
535
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.1
10.3
42
138
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
10.3
152
882
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
10.3
175
1061
J01DA01
ATC
[U] cefalexin
1.6
10.3
537
4330
L04AA13
ATC
[U] leflunomide
3.8
10.2
31
84
C08CA13
ATC
lercanidipine; oral
1.9
10.2
143
816
E66.8
ICD-10 Finland
Other obesity
2.8
10.2
53
200
ZX108
NOMESCO Finland
Inhalation
13.3
10.2
17
13
I50
ICD-10 Finland
Heart failure
3.2
10.2
41
134
207
Kela drug reimbursment
Chronic arrhythmias
1.9
10.2
155
909
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.8
10.1
30
80
SPAT1153
SPAT
Removal of sutures
1.6
10.1
283
1967
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.5
10.1
35
104
XQ800
NOMESCO Finland
Prick test
2.5
10.0
66
280
S21
ICPC
Skin texture symptom/complaint
1.9
10.0
131
731
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
9.9
97
487
R4110
NOMESCO Finland
Physiotherapy
1.7
9.9
246
1656
SPAT1255
SPAT
Intravenous administration of medicine
2.4
9.9
67
288
S19
ICPC
Skin injury other
2.9
9.9
45
158
QDA10
NOMESCO Finland
Incision of skin of lower limb
12.4
9.9
17
14
S11
ICPC
Skin infection post-traumatic
5.2
9.9
20
39
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
26.3
9.8
13
5
A11CC03
ATC
alfacalcidol; systemic
4.1
9.8
27
68
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
9.7
333
2425
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
9.7
173
1064
WX723
NOMESCO Finland
CPAP therapy
3.0
9.6
43
150
A02BC05
ATC
esomeprazole; systemic
1.6
9.5
354
2624
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.5
9.5
32
93
M05BA07
ATC
risedronic acid; oral
3.1
9.5
39
129
R4190
NOMESCO Finland
Nutritional therapy
3.1
9.5
39
129
R5110, ,
SPAT
2.3
9.5
70
313
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.9
9.5
27
70
R11
ICD-10 Finland
Nausea and vomiting
2.1
9.4
87
427
L59.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue related to radiation, unspecified
+∞
9.4
9
*
L94.2
ICD-10 Finland
Calcinosis cutis
+∞
9.4
9
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
9.4
232
1558
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
9.3
102
534
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
9.3
83
402
QXB99, ,
SPAT
3.9
9.3
27
71
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
9.3
306
2205
C02AC05
ATC
moxonidine; oral
2.6
9.2
55
223
C09BA02
ATC
enalapril and diuretics; systemic
2.2
9.1
80
386
S99
ICPC
Skin disease other
3.7
9.0
28
77
ZXC50
NOMESCO Finland
Cryotherapy
3.3
9.0
33
102
J01FA06
ATC
roxithromycin; oral
1.6
8.9
343
2554
C08CA01
ATC
amlodipine; oral
1.6
8.9
344
2564
L30.8
ICD-10 Finland
Other specified dermatitis
3.7
8.9
28
78
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
8.9
38
129
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
8.8
332
2458
D07AA02
ATC
hydrocortisone; topical
1.9
8.8
124
707
T90
ICPC
Diabetes non-insulin dependent
1.7
8.8
210
1394
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
8.8
44
163
A12BA01
ATC
potassium chloride; oral
2.5
8.7
53
217
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
50.5
8.7
10
*
WZA10
NOMESCO Finland
Extensive medical or dental certificate
4.5
8.6
21
48
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
8.6
158
977
C01AA05
ATC
digoxin; systemic
2.1
8.6
83
415
R03AC02
ATC
salbutamol; inhalant
1.5
8.6
471
3777
I77.6
ICD-10 Finland
Arteritis, unspecified
16.5
8.6
13
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
8.5
69
321
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.1
8.5
35
116
S01
ICPC
Pain/tenderness of skin
2.6
8.4
48
190
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
8.4
43
161
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
8.4
216
1459
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.3
8.4
31
96
S91.0
ICD-10 Finland
Open wound of ankle
8.0
8.4
18
23
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
+∞
8.3
8
*
L95.1
ICD-10 Finland
Erythema elevatum diutinum
+∞
8.3
8
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.6
8.3
17
20
N06AX21
ATC
duloxetine; oral
1.9
8.3
102
556
C08CA02
ATC
felodipine; oral
2.0
8.3
92
484
M10.0
ICD-10 Finland
Idiopathic gout
2.9
8.3
37
129
UKC02
NOMESCO Finland
Cystoscopy
1.8
8.2
142
862
D05BB02
ATC
acitretin; oral
3.8
8.2
25
68
NGQ20
NOMESCO Finland
Amputation of lower leg
14.6
8.2
13
9
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.2
209
1410
WX892
NOMESCO Finland
Monitored bed care
2.1
8.2
74
361
L50.0
ICD-10 Finland
Allergic urticaria
3.4
8.1
28
83
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.4
8.1
29
88
WX212
NOMESCO Finland
Femoral plexus blockade
3.4
8.1
29
88
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
8.1
298
2187
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
8.1
232
1609
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.7
7.9
145
894
K07
ICPC
Swollen ankles/oedema
2.4
7.9
52
221
N30.0
ICD-10 Finland
Acute cystitis
1.7
7.9
141
864
WX002
NOMESCO Finland
Sedation and analgesia
1.7
7.9
172
1113
N02BF02
ATC
pregabalin; oral
2.3
7.9
57
253
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
7.9
124
732
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
7.9
203
1371
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
7.8
68
326
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
9.5
7.8
15
16
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.7
7.8
42
162
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.8
366
2824
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
7.8
68
327
UJF92
NOMESCO Finland
Capsular endoscopy
3.7
7.8
24
66
SPAT1301
SPAT
No procedures
1.5
7.7
268
1937
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.6
7.7
25
71
M31.3
ICD-10 Finland
Wegener granulomatosis
15.2
7.7
12
8
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
15.2
7.7
12
8
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
4.6
7.7
18
40
SPAT1229
SPAT
Assessment of need for aid
2.1
7.6
74
371
J01FA10
ATC
azithromycin; systemic
1.5
7.6
468
3806
SPAT1310
SPAT
Counselling related to known health issue
1.5
7.6
267
1936
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.5
7.5
47
195
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
7.5
42
165
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
7.5
83
436
40199
ICD-8 Finland
Essential benign hypertension
3.7
7.5
23
63
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.0
7.5
32
109
J01AA02
ATC
doxycycline; systemic
1.5
7.4
664
5808
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.4
329
2501
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.0
7.4
19
32
PE1AT
NOMESCO Finland
Femoral artery PTA
6.0
7.4
19
32
D01AE15
ATC
terbinafine; topical
2.1
7.4
66
320
C07AB02
ATC
metoprolol; systemic
1.6
7.4
182
1214
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
7.4
256
1849
S06
ICPC
Rash localized
2.3
7.4
53
235
C01DA14
ATC
isosorbide mononitrate; oral
1.7
7.3
144
905
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
7.3
7
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.2
7.3
19
46
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
4.2
7.3
19
46
WW200
NOMESCO Finland
Immunization
3.4
7.3
25
74
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
7.3
41
162
A10BA02
ATC
metformin; oral
1.5
7.2
249
1793
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
7.2
140
878
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
30.3
7.2
9
*
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
20.2
7.1
10
5
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
20.2
7.1
10
5
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
7.1
191
1299
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
7.1
60
285
C09AA02
ATC
enalapril; systemic
1.6
7.1
172
1142
E86
ICD-10 Finland
Volume depletion
3.2
7.0
27
86
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.4
7.0
48
208
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
7.0
32
113
R1250
NOMESCO Finland
Evaluation of functional capability
3.4
7.0
25
76
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.4
7.0
46
196
J01CE08
ATC
benzathine benzylpenicillin; parenteral
6.4
7.0
17
27
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.5
6.9
43
178
ED1AA
NOMESCO Finland
Mandibular X-ray examination
7.6
6.9
15
20
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
6.9
30
103
A02BA02
ATC
ranitidine; systemic
1.6
6.9
173
1158
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
6.9
44
185
S17
ICPC
Abrasion/scratch/blister
3.3
6.9
25
77
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.3
6.9
25
77
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.3
6.9
25
77
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.8
139
881
A10BH01
ATC
sitagliptin; oral
1.9
6.8
90
502
L50.1
ICD-10 Finland
Idiopathic urticaria
8.3
6.8
14
17
A01AB09
ATC
miconazole; local oral
2.0
6.8
79
422
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
6.8
96
547
JN4BD
NOMESCO Finland
Extensive body CT
1.8
6.8
96
547
RJ411, ,
NOMESCO Finland
11.0
6.8
12
11
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.3
6.8
17
40
QXA05
NOMESCO Finland
Skin division, unspecified location
16.8
6.8
10
6
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.7
31
110
M25.5
ICD-10 Finland
Pain in joint
1.5
6.7
258
1897
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.9
6.7
19
49
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
6.7
97
557
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
6.7
55
258
R06AX22
ATC
ebastine; oral
1.7
6.7
138
878
R01AD08
ATC
fluticasone; nasal
1.5
6.7
225
1609
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
6.6
55
259
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
6.6
86
478
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
6.6
57
273
S20
ICPC
Corn/callosity
3.5
6.6
22
64
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
6.6
71
370
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.3
6.6
24
74
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
6.6
137
874
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
6.5
52
241
N18.0
ICD-10 Finland
End-stage renal disease
6.9
6.5
15
22
SPAT1312
SPAT
General health counselling
1.5
6.5
255
1881
A07AA02
ATC
nystatin; oral
2.2
6.5
53
248
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.7
6.5
20
55
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.7
6.5
20
55
R31
ICD-10 Finland
Unspecified haematuria
1.8
6.5
90
511
V03AE01
ATC
polystyrene sulfonate; oral
5.8
6.5
17
30
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.3
6.4
23
70
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.3
6.4
47
210
ZXA10
NOMESCO Finland
Bilateral
1.6
6.4
165
1109
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
7.5
6.4
14
19
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
6.4
135
864
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
3.8
6.4
19
51
M05BX04
ATC
denosumab; parenteral
2.1
6.4
57
277
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
4.1
6.4
17
42
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.5
6.4
39
161
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
6.3
20
56
ZXA00
NOMESCO Finland
Right side
1.5
6.3
225
1627
L08.0
ICD-10 Finland
Pyoderma
9.3
6.3
12
13
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
6.3
193
1351
A10BH05
ATC
linagliptin; oral
2.2
6.3
50
232
JAH01
NOMESCO Finland
Laparoscopy
2.5
6.3
39
162
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
6.3
72
384
L94.8
ICD-10 Finland
Other specified localized connective tissue disorders
+∞
6.3
6
*
TNX92, ,
SPAT
+∞
6.3
6
*
M30
ICD-10 Finland
Polyarteritis nodosa and related conditions
+∞
6.3
6
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
6.3
54
259
C09CA06
ATC
candesartan; oral
1.5
6.2
192
1345
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.2
233
1701
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.1
6.2
14
20
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
6.2
105
632
SPAT1254
SPAT
Administration of medicine
1.7
6.2
133
854
WW500
NOMESCO Finland
Blood transfusion
2.4
6.2
40
169
J01CF02
ATC
cloxacillin; systemic
3.4
6.2
21
62
A02BC03
ATC
lansoprazole; oral
1.5
6.1
244
1804
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
3.8
6.1
18
48
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
4.2
6.1
16
39
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.8
6.1
29
105
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
6.1
109
667
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.9
6.1
27
94
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
12.6
6.1
10
8
V03AE02
ATC
sevelamer; oral
12.6
6.1
10
8
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
12.6
6.1
10
8
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
6.1
62
317
-56
ICPC
Dressing/pressure/compress/tamponade
3.6
6.1
19
53
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.6
6.1
19
53
XA421
NOMESCO Finland
Nocturnal polygraphy
10.1
6.0
11
11
M35.1
ICD-10 Finland
Other overlap syndromes
10.1
6.0
11
11
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
6.0
267
2014
N06AA09
ATC
amitriptyline; systemic
1.8
6.0
85
485
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.9
6.0
17
44
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.0
582
5051
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
382
285
22.52
307.65
1.9
1.4
34.08
8.81
u/ml
—
9
8
312
224
20.77
307.65
1.9
1.6
97.33
210.00
titre
—
15
10
327
193
26.01
307.65
1.8
1.5
0.24
0.23
g/l
0.30
314
185
326
199
25.09
307.65
1.8
1.5
1.22
1.18
g/l
0.95
314
190
269
227
16.46
279.96
1.4
1.2
1.47
2.01
u/ml
0.12
18
14
175
206
10.30
141.79
2.5
1.8
—
—
—
0
0
258
591
5.71
111.49
2.3
3.0
67.16
66.55
g/l
0.52
242
532
135
171
9.11
102.27
1.3
1.2
4.52
12.87
u/ml
0.60
19
26
133
170
9.00
99.96
1.4
1.2
10.09
2.68
u/ml
0.50
11
17
119
137
9.85
96.96
1.3
1.2
1.32
9.68
u/ml
—
6
10
654
3391
4.38
90.97
12.4
5.7
2.63
2.87
%
1.84
638
3151
654
3444
4.27
87.62
11.8
5.6
61.19
57.54
%
12.28
635
3216
658
3494
4.27
86.74
12.6
5.8
24.36
27.47
%
10.60
640
3262
93
95
10.80
82.39
1.3
1.2
3.41
4.74
u/ml
0.20
41
31
212
533
4.89
80.20
4.2
2.7
11.11
10.80
g/l
0.33
199
484
106
134
8.83
79.94
1.4
1.2
48.19
43.64
u/ml
—
13
7
719
4200
4.51
79.36
14.9
9.0
4.81
4.11
e9/l
11.48
669
3674
238
671
4.46
77.69
2.9
2.0
321.04
373.74
nmol/l
3.77
227
617
180
426
5.03
72.83
2.1
1.6
1.24
1.31
g/l
0.19
165
391
66
55
12.87
66.63
1.3
1.2
138.13
110.00
titre
—
16
9
137
278
5.63
65.80
2.3
2.4
4.15
3.52
g/l
4.19
132
251
375
1585
3.34
65.72
4.3
2.4
5.52
5.79
e6/l
0.13
355
1440
137
279
5.61
65.53
2.3
2.4
7.35
7.43
g/l
0.18
132
251
137
279
5.61
65.53
2.3
2.4
—
—
—
0
0
522
2685
3.24
65.35
5.5
3.0
—
—
—
0
0
122
234
5.87
62.15
2.7
2.8
0.58
1.23
g/l
1.07
109
205
236
769
3.80
61.76
6.0
3.3
—
—
—
0
0
434
2064
3.13
61.21
5.2
3.0
0.27
0.50
e6/l
2.88
383
1581
459
2266
3.09
60.37
5.4
3.1
80.60
90.06
e6/l
0.06
406
1765
127
261
5.50
59.97
2.4
2.5
10.78
10.58
g/l
0.17
122
232
113
210
6.01
59.43
2.5
2.7
0.03
0.03
g/l
0.10
108
194
125
260
5.42
58.18
2.4
2.5
3.10
3.02
g/l
0.34
120
232
494
2622
2.95
55.63
6.4
3.6
76.04
113.53
e6/l
0.44
423
1885
44
28
16.47
51.48
1.1
1.1
1.04
1.07
ratio
—
26
10
191
615
3.67
50.03
2.6
2.4
77.45
70.06
e9/l
1.44
143
480
101
199
5.59
49.70
2.6
2.8
0.01
0.00
g/l
0.50
96
183
228
828
3.35
49.42
3.3
2.5
2.01
1.80
%
2.02
204
727
251
976
3.18
48.45
3.5
2.3
20.63
22.33
%
1.00
224
832
70
98
7.66
48.05
1.4
1.2
2.69
6.41
u/ml
0.93
32
44
99
198
5.49
47.89
2.6
1.5
—
—
—
0
0
60
71
8.98
47.30
1.5
1.1
—
—
u/ml
—
0
0
105
225
5.15
46.97
2.6
2.6
37.22
37.60
g/l
0.23
100
197
272
1135
3.00
46.12
3.3
2.3
11.24
12.79
umol/l
3.11
260
1055
243
961
3.09
45.22
7.4
4.9
1.09
1.04
mmol/l
1.65
231
879
214
787
3.25
45.06
4.2
4.1
244.59
254.67
u/l
0.34
207
737
278
1190
2.93
44.84
1.4
1.3
33.58
33.25
iu/ml
0.02
89
381
530
3173
2.63
43.35
7.8
4.6
33.57
35.44
g/l
10.79
508
2940
252
1039
2.98
43.34
3.4
2.3
2.27
2.34
g/l
1.10
237
960
92
201
4.98
40.10
1.4
1.3
—
—
—
0
0
74
133
5.97
39.99
4.8
3.4
61.05
57.90
%
1.10
74
133
73
130
6.02
39.82
4.6
3.2
4.64
4.28
e9/l
0.60
73
130
174
618
3.25
38.36
8.3
6.5
11.50
9.86
mmol/l
1.93
166
583
745
5450
3.11
38.34
8.4
3.9
18.82
12.45
mm/h
16.11
716
5011
563
3611
2.49
37.62
6.1
3.7
0.00
0.00
estimate
0.50
220
719
179
668
3.10
36.15
2.6
2.3
0.20
0.21
g/l
0.59
169
622
561
3647
2.42
35.54
6.2
3.7
0.00
0.00
estimate
0.50
203
644
556
3602
2.42
35.47
7.8
5.0
0.00
0.00
estimate
0.50
216
671
256
1168
2.66
35.43
3.7
3.3
0.79
0.82
mmol/l
4.68
241
1102
561
3683
2.38
34.20
9.1
6.5
1.21
1.21
mmol/l
1.05
440
3121
344
1850
2.39
33.09
3.1
2.2
3.39
3.06
mg/l
1.30
309
1545
537
3491
2.33
33.04
24.1
15.5
1.30
1.28
inr
0.29
237
1010
163
606
3.06
32.94
5.0
3.5
1.22
1.23
mmol/l
1.09
149
529
102
284
3.92
32.41
1.7
2.0
38.97
38.72
u/l
0.04
83
252
521
3363
2.30
32.33
7.9
5.9
1.21
1.21
mmol/l
0.93
477
3042
131
434
3.36
32.06
1.6
1.2
257.15
282.87
u/ml
0.10
125
394
47
66
7.46
32.05
1.8
2.4
—
—
—
0
0
478
2997
2.27
31.56
2.9
2.2
77.53
77.20
nmol/l
0.09
445
2658
748
5702
2.83
31.40
13.3
7.3
81.78
78.25
u/l
1.59
724
5329
351
1949
2.31
30.91
7.0
3.9
0.00
0.01
estimate
0.69
208
642
339
1871
2.30
30.12
3.7
2.6
4149.39
8224.24
umol/l
1.00
307
1623
565
3839
2.26
30.06
8.1
6.2
10.89
11.51
umol/l
0.89
547
3640
78
189
4.42
29.81
4.0
3.9
1.83
1.59
mg/l
0.95
72
169
70
157
4.75
29.44
5.9
4.3
2.97
2.65
mmol/l
0.32
53
104
270
1372
2.38
28.87
1.9
1.5
3.33
2.47
g/l
4.60
210
817
86
231
4.01
28.66
3.2
4.0
40.12
46.66
mg/l
0.19
67
192
481
3107
2.17
28.47
3.9
2.7
172.97
133.52
ug/l
1.15
447
2838
44
66
6.96
28.26
2.6
2.3
—
—
—
0
0
66
146
4.80
28.21
4.2
2.1
15.81
15.87
%
0.03
37
72
52
93
5.87
28.15
1.2
1.1
—
—
—
0
0
85
230
3.98
28.03
3.3
4.0
58.27
84.21
mg/l
0.44
66
190
84
228
3.96
27.58
3.3
3.9
2.46
1.93
ratio
—
10
22
50
88
5.96
27.51
1.2
1.1
132.48
117.93
%
1.13
50
81
243
1220
2.36
26.39
2.4
1.8
—
—
—
0
0
139
537
2.88
25.89
2.4
1.5
—
—
—
0
0
72
183
4.19
25.82
1.9
2.8
216.51
194.45
%
1.02
67
176
362
2171
2.11
25.11
4.1
3.1
436.86
294.88
mg/l
0.23
258
1350
223
1102
2.36
24.95
2.2
2.0
30.18
29.67
s
0.70
218
1066
94
295
3.44
24.88
2.7
1.8
2.39
2.80
ug/l
0.11
86
259
600
4351
2.13
24.77
6.2
4.7
6.90
6.70
mmol/l
1.29
579
4075
99
322
3.33
24.76
1.5
2.0
1.50
1.51
g/l
0.06
84
279
70
180
4.13
24.71
1.8
2.1
10.75
11.90
mg/l
0.46
63
166
374
2295
2.08
24.18
5.2
3.6
16.44
8.91
mg/mmol
1.61
271
1423
31
37
8.64
24.12
1.2
1.2
—
—
—
0
0
74
205
3.84
23.56
1.6
1.6
0.21
0.08
iu/ml
0.49
23
47
374
2312
2.06
23.54
4.3
3.0
6.78
7.61
mmol/l
3.40
323
1926
55
124
4.66
22.95
4.3
5.2
1384.67
300.40
iu/ml
—
6
15
361
2224
2.04
22.75
2.6
2.1
143.54
265.69
u/l
1.95
335
2092
36
55
6.78
22.70
1.3
1.2
—
—
—
0
0
36
55
6.78
22.70
1.3
1.2
—
—
—
0
0
362
2238
2.03
22.54
4.1
3.1
1908.67
1389.11
ng/l
1.54
325
1899
36
56
6.65
22.33
1.3
1.2
—
—
—
0
0
36
56
6.65
22.33
1.3
1.2
—
—
—
0
0
36
56
6.65
22.33
1.3
1.2
—
—
—
0
0
643
4903
2.08
21.64
7.0
4.5
8.86
3005.07
e6/l
—
7
83
422
2805
1.95
20.90
6.6
3.8
—
—
—
0
0
213
1136
2.15
19.27
1.4
1.3
8.70
12.88
u/ml
0.60
72
414
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
74
244
3.21
18.02
4.1
2.7
0.30
0.37
u/ml
1.34
46
133
170
857
2.21
17.59
2.2
1.8
—
—
—
0
0
215
1187
2.07
17.58
4.3
2.9
3.60
2.56
e6/l
0.74
136
651
293
1810
1.92
17.32
1.9
1.5
19.57
21.03
nmol/l
0.80
255
1511
169
857
2.20
17.20
2.2
1.7
—
—
—
0
0
25
35
7.32
17.02
2.5
1.7
—
—
—
0
0
266
1599
1.94
17.01
1.9
1.7
1.21
1.23
mg/l
0.06
224
1212
23
9
26.17
16.96
1.1
1.0
—
—
—
0
0
145
702
2.27
16.48
5.9
3.8
1.78
2.14
mmol/l
0.61
127
573
72
247
3.08
16.40
2.0
2.0
253.77
437.83
ug/l
0.48
61
231
347
2303
1.82
16.11
3.3
2.5
52.63
61.82
u/l
2.47
316
2128
375
2548
1.81
16.10
3.9
3.4
2.34
2.35
mmol/l
1.14
337
2228
218
1254
1.97
15.70
4.1
2.7
0.90
1.16
e6/l
0.76
138
713
125
582
2.33
15.53
5.7
3.5
102.37
81.96
ng/l
1.54
112
506
54
164
3.44
14.99
1.5
1.5
—
—
—
0
0
36
85
4.37
14.19
1.3
1.7
—
—
—
0
0
97
420
2.47
14.13
1.8
1.5
—
—
—
0
0
28
57
5.04
13.17
1.3
1.7
—
—
—
0
0
53
173
3.19
13.13
1.3
1.6
—
—
—
0
0
279
1833
1.76
12.80
5.8
3.7
86.48
89.60
%
1.05
272
1786
233
1453
1.81
12.76
1.9
1.7
1338.37
1190.28
nmol/l
1.50
184
1087
66
249
2.78
12.68
2.7
3.0
—
—
—
0
0
339
2363
1.70
12.49
3.7
3.2
36.52
32.78
u/l
0.66
307
2247
38
104
3.77
12.32
1.3
1.6
—
—
—
0
0
151
828
1.99
12.23
3.1
2.3
127.56
134.40
ug/g
0.12
121
655
43
131
3.40
11.90
1.3
1.2
284.61
254.60
u/ml
0.22
23
73
97
453
2.28
11.89
5.5
3.6
2.28
1.98
mmol/l
0.35
76
335
58
214
2.83
11.62
1.3
1.1
—
—
—
0
0
42
128
3.39
11.62
1.5
1.7
—
—
—
0
0
40
119
3.47
11.48
1.4
1.4
112.08
111.94
u/ml
0.00
13
16
43
137
3.25
11.10
1.2
1.2
—
—
—
0
0
391
2898
1.62
10.94
5.8
3.7
60.21
49.35
ng/l
0.20
302
2047
151
860
1.91
10.87
5.8
7.8
1.36
1.29
mmol/l
0.06
116
678
37
109
3.50
10.79
1.4
1.3
—
—
—
0
0
244
1608
1.71
10.78
2.0
1.7
427.17
24066204.82
pmol/l
1.42
202
1338
47
165
2.95
10.31
4.1
1.9
125.64
127.00
g/l
0.12
42
118
48
173
2.87
10.06
1.4
1.6
—
—
—
0
0
47
168
2.90
9.99
1.4
1.6
—
—
—
0
0
725
6323
1.75
9.95
37.9
17.1
15.02
15.03
%
0.02
717
6214
20
39
5.22
9.87
1.9
1.7
5.93
6.56
u/l
0.05
14
33
812
7343
2.06
9.81
35.1
14.0
21.90
24.19
mg/l
1.61
749
5796
147
863
1.84
9.57
5.9
7.8
5.02
5.11
kpa
0.51
137
824
42
146
2.97
9.39
1.6
1.3
—
—
—
0
0
42
146
2.97
9.39
1.6
1.3
—
—
—
0
0
146
864
1.82
9.25
5.9
7.8
11.61
12.09
kpa
0.63
137
826
231
1557
1.65
9.18
1.3
1.2
1.66
1.81
u/ml
0.07
76
403
20
42
4.85
9.09
2.6
1.7
459.00
498.88
e6/l
0.14
15
34
18
20
9.16
9.05
1.3
1.1
0.32
0.28
g/l
0.92
13
15
105
565
1.97
8.88
4.7
2.6
56.12
66.17
ml/min/173m2
2.02
64
230
654
5621
1.59
8.74
4.4
3.8
15.17
14.86
pmol/l
2.34
589
5062
117
658
1.89
8.68
2.6
2.3
46.51
35.65
u/l
0.51
105
556
44
167
2.72
8.40
3.6
2.9
33.56
33.67
umol/l
0.01
39
147
139
834
1.79
8.38
3.1
2.7
9.02
8.12
umol/l
0.22
119
715
431
3410
1.51
8.26
3.1
2.6
—
—
—
0
0
395
3074
1.51
8.17
2.3
2.0
90.65
94.65
pmol/l
0.90
229
1561
212
1442
1.61
7.99
3.3
3.1
2.48
2.45
mmol/l
3.10
188
1266
31
100
3.17
7.89
1.3
1.5
—
—
—
0
0
28
85
3.37
7.84
2.6
1.5
53.20
62.08
%
0.43
15
62
86
453
1.99
7.73
2.3
2.4
16.56
20.35
au/ml
—
5
31
33
114
2.97
7.50
1.1
1.1
—
—
—
0
0
204
1402
1.59
7.30
4.9
4.0
275.12
338.75
ng/l
0.18
164
1116
37
139
2.73
7.23
1.6
1.6
—
—
—
0
0
175
1164
1.62
7.16
1.6
1.5
—
—
—
0
0
35
129
2.78
7.09
1.2
1.2
89.37
45.10
u/l
0.42
26
114
561
4780
1.46
6.82
4.3
3.1
69.10
48.67
u/l
4.63
515
4439
13
14
9.40
6.80
2.8
1.5
—
—
—
0
0
22
64
3.50
6.59
1.2
1.3
—
—
—
0
0
28
95
3.01
6.58
1.3
1.5
—
—
—
0
0
33
125
2.70
6.38
1.3
1.5
—
—
—
0
0
30
108
2.84
6.37
1.3
1.5
—
—
—
0
0
46
205
2.31
6.34
1.8
1.4
—
—
—
0
0
17
46
3.75
5.66
1.4
1.5
—
—
—
0
0
745
6813
1.54
5.60
7.1
5.7
41.35
39.91
mmol/mol
3.36
695
6268
13
20
6.58
5.57
1.1
1.1
—
—
—
0
0
102
638
1.68
5.27
4.1
3.1
254.64
219.07
ng/l
0.38
93
590
755
6952
1.53
5.20
30.4
13.1
77.59
79.58
ml/min/173m2
1.44
693
5703
15
40
3.80
5.10
3.3
4.3
—
—
—
0
0
738
6771
1.49
5.10
5.4
4.6
2.01
1.92
mu/l
0.33
676
6141
16
37
4.38
4.95
1.4
1.6
—
—
—
0
0
16
38
4.27
4.83
1.4
1.6
—
—
—
0
0
76
450
1.75
4.80
2.4
1.6
—
—
—
0
0
505
4368
1.35
4.76
3.2
2.9
—
—
—
0
0
13
26
5.06
4.64
4.2
3.7
—
—
—
0
0
22
81
2.76
4.54
1.3
1.3
—
—
—
0
0
18
59
3.09
4.53
1.4
2.3
738.75
617.63
ml
0.33
12
38
62
361
1.77
4.17
5.8
3.1
25.29
25.21
mmol/l
0.06
62
353
14
35
4.05
4.11
1.0
1.3
—
—
—
0
0
36
176
2.09
4.05
3.7
3.3
0.82
0.88
nmol/l
0.27
26
139
9
14
6.48
3.99
1.0
1.2
—
—
—
0
0
806
7620
1.54
3.94
35.1
16.4
139.11
139.65
mmol/l
7.40
791
7414
10
19
5.31
3.83
1.1
1.1
—
—
—
0
0
824
7839
1.59
3.79
20.2
10.1
26.63
25.93
u/l
0.67
803
7548
24
103
2.37
3.69
1.4
1.5
33.99
31.67
g/l
0.26
17
90
806
7639
1.52
3.68
35.5
16.5
3.98
3.98
mmol/l
0.16
788
7420
12
31
3.91
3.50
1.8
2.5
954.17
726.84
u/ml
0.36
12
31
14
47
3.01
3.42
1.1
1.2
—
—
—
0
0
14
47
3.01
3.42
1.1
1.2
—
—
—
0
0
13
42
3.13
3.38
1.3
1.2
5.26
7.99
u/l
0.79
13
35
36
190
1.93
3.33
2.0
2.3
116.19
56.40
ug/min
0.53
20
114
32
162
2.01
3.33
1.3
1.4
12.53
8.96
u/l
0.69
24
125
18
71
2.57
3.31
2.4
1.5
—
—
—
0
0
13
43
3.05
3.26
1.0
1.0
—
—
—
0
0
35
185
1.93
3.23
1.8
1.7
10726.85
16966.97
e6/l
0.64
26
137
9
20
4.53
3.12
1.2
1.2
—
—
—
0
0
6
8
7.54
3.06
1.3
1.4
—
—
—
0
0
6
8
7.54
3.06
11.0
11.4
4.82
6.10
mmol/l
—
6
8
17
68
2.53
3.05
1.1
1.1
—
—
—
0
0
23
106
2.20
3.05
1.1
1.1
—
—
—
0
0
7
12
5.87
3.02
1.1
1.3
—
—
—
0
0
7
12
5.87
3.02
1.4
1.4
—
—
—
0
0
12
38
3.19
2.86
1.3
1.5
—
—
—
0
0
9
23
3.94
2.78
1.3
1.1
11.92
8.85
ug/l
—
9
23
10
30
3.36
2.60
1.1
1.2
133.90
183.42
mmol/24h
—
10
30
8
20
4.03
2.57
3.4
1.6
—
—
—
0
0
35
580
0.59
2.51
1.5
1.7
—
—
—
0
0
8
21
3.83
2.46
1.0
1.0
—
—
—
0
0
8
21
3.83
2.46
1.1
1.0
—
—
—
0
0
32
181
1.80
2.46
1.3
1.3
213.00
230.75
miu/ml
—
7
82
31
174
1.81
2.45
1.2
1.1
—
—
—
0
0
19
90
2.14
2.40
1.4
1.4
1670.33
1513.68
e6/l
0.08
12
63
30
168
1.81
2.39
1.5
2.1
3104.53
2424.38
u/l
—
8
68
10
33
3.05
2.36
1.0
1.0
—
—
—
0
0
109
827
1.36
2.29
2.0
1.8
1.79
1.46
%
2.89
91
723
10
34
2.96
2.28
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
34
2.96
2.28
1.1
1.1
—
—
—
0
0
10
34
2.96
2.28
1.1
1.1
—
—
—
0
0
9
29
3.12
2.23
1.1
1.1
—
—
—
0
0
85
623
1.40
2.20
2.6
2.5
5.66
7.00
ug/l
0.58
71
544
17
80
2.15
2.19
1.5
1.4
11472.25
47776.83
e6/l
—
8
47
210
1754
1.26
2.18
3.1
2.3
—
—
—
0
0
16
74
2.18
2.15
1.0
1.3
—
—
—
0
0
45
293
1.56
2.10
2.6
1.8
—
—
—
0
0
8
25
3.22
2.10
1.0
1.0
1302.25
1539.04
miu/ml
—
8
25
35
214
1.66
2.09
1.4
1.4
264.32
296.13
ug/g
0.41
22
132
9
31
2.92
2.07
1.1
1.8
—
1224630.00
—
0
5
6
15
4.02
2.04
1.0
1.0
—
—
—
0
0
69
943
0.71
2.03
5.2
4.5
32.16
32.29
%
0.04
50
623
11
44
2.52
2.01
1.3
1.2
—
—
—
0
0
28
163
1.74
2.00
1.6
1.3
—
—
—
0
0
36
225
1.62
1.99
1.6
1.6
—
—
—
0
0
25
142
1.78
1.94
1.1
1.7
6.38
31.39
e6/l
0.57
16
113
25
142
1.78
1.94
1.2
1.7
4.82
916.35
e6/l
0.64
17
117
18
93
1.95
1.86
1.4
1.2
0.53
0.60
nmol/l
0.64
18
87
13
60
2.18
1.78
2.6
2.4
1.63
3.14
u/field
—
8
21
30
185
1.64
1.77
1.4
1.3
—
—
—
0
0
41
274
1.52
1.74
2.4
1.6
—
—
—
0
0
12
54
2.24
1.74
1.0
1.1
—
—
—
0
0
11
48
2.31
1.71
1.3
2.7
42.40
38.00
%
—
5
23
61
445
1.40
1.67
1.2
1.2
133.05
132.45
iu/ml
0.00
30
189
6
19
3.17
1.66
2.3
1.8
132.83
104.11
nmol/24h
—
6
19
21
120
1.77
1.63
1.5
1.5
—
—
—
0
0
21
120
1.77
1.63
1.5
1.5
—
—
—
0
0
13
63
2.08
1.60
1.5
1.3
—
—
—
0
0
7
26
2.71
1.58
2.7
3.2
—
—
—
0
0
7
26
2.71
1.58
2.7
3.2
—
—
—
0
0
37
252
1.49
1.47
1.6
1.4
21.42
29.01
iu/l
0.82
31
211
7
28
2.51
1.45
1.6
1.3
73.71
93.00
nmol/l
—
7
20
837
8174
1.33
1.44
46.1
20.8
39.19
40.05
%
4.06
804
7608
6
22
2.74
1.43
1.2
2.3
—
—
—
0
0
837
8176
1.33
1.42
46.3
20.7
253.97
247.77
e9/l
1.57
823
7957
837
8179
1.32
1.39
46.3
20.7
4.32
4.48
e12/l
13.51
822
7934
16
89
1.81
1.38
1.1
1.0
—
—
—
0
0
18
104
1.75
1.37
1.1
1.1
—
—
—
0
0
837
8182
1.32
1.36
46.7
20.8
129.77
135.06
g/l
19.44
828
8045
742
7161
1.20
1.34
5.0
4.6
6.02
5.96
mmol/l
0.29
674
6478
10
47
2.14
1.34
1.0
1.3
—
—
—
0
0
12
61
1.98
1.33
1.7
1.5
—
—
—
0
0
12
61
1.98
1.33
1.7
1.5
—
—
—
0
0
12
61
1.98
1.33
1.7
1.5
—
—
—
0
0
9
43
2.10
1.30
1.7
1.2
—
—
—
0
0
9
43
2.10
1.30
1.7
1.2
—
—
—
0
0
14
243
0.57
1.29
1.1
1.7
—
—
—
0
0
13
69
1.90
1.29
1.8
1.3
9311.67
160269.80
e6/l
—
6
45
33
231
1.44
1.19
1.3
1.1
—
—
—
0
0
185
1624
1.18
1.16
7.3
3.9
1.01
1.02
kg/l
0.53
25
230
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
96
800
1.22
1.06
3.8
4.3
83.09
29.23
ug/l
0.49
78
666
9
47
1.92
1.02
1.3
1.6
—
—
—
0
0
7
35
2.01
1.00
1.6
1.1
—
—
—
0
0
7
36
1.95
0.97
2.0
1.5
—
—
—
0
0
7
36
1.95
0.97
2.0
1.5
—
—
—
0
0
716
6943
1.15
0.96
4.2
3.9
1.42
1.29
mmol/l
3.64
647
6300
14
85
1.66
0.94
1.3
1.5
—
—
—
0
0
14
85
1.66
0.94
3.6
3.4
—
—
—
0
0
14
85
1.66
0.94
1.3
1.5
—
—
—
0
0
53
663
0.79
0.93
2.7
2.0
—
—
—
0
0
9
52
1.74
0.92
1.4
1.8
20.67
21.79
nmol/l
—
9
47
6
30
2.01
0.87
2.7
1.4
25.33
29.50
umol/l
—
6
30
47
372
1.28
0.84
1.3
1.3
—
—
—
0
0
8
45
1.78
0.84
1.1
2.0
—
—
—
0
0
757
7396
1.15
0.79
5.0
4.9
2.51
2.74
mmol/l
9.58
678
6776
51
412
1.25
0.79
2.8
3.2
4.10
4.52
pmol/l
2.57
44
373
17
115
1.49
0.77
1.2
1.1
0.51
2.68
u/ml
—
9
65
6
34
1.77
0.76
1.8
1.1
—
—
—
0
0
6
34
1.77
0.76
1.8
1.1
—
—
—
0
0
12
75
1.61
0.75
1.7
1.6
—
—
—
0
0
49
599
0.81
0.74
2.7
1.9
—
—
—
0
0
30
228
1.33
0.73
1.3
1.1
—
—
—
0
0
7
38
1.85
0.73
1.1
1.6
—
—
—
0
0
7
38
1.85
0.73
1.1
1.6
—
—
—
0
0
11
68
1.63
0.72
1.1
1.1
—
—
—
0
0
9
57
1.58
0.71
1.3
1.1
1.31
1.51
nmol/l
—
9
49
5
26
1.93
0.70
2.4
1.6
—
—
—
0
0
5
26
1.93
0.70
2.4
1.6
—
—
—
0
0
742
7257
1.13
0.69
4.7
4.4
4.38
4.65
mmol/l
9.68
669
6689
12
77
1.57
0.68
1.7
1.7
—
—
—
0
0
5
27
1.86
0.68
2.4
1.6
—
—
—
0
0
11
70
1.58
0.65
1.7
1.7
—
—
—
0
0
10
62
1.62
0.65
1.0
1.0
—
—
—
0
0
21
155
1.36
0.63
1.0
1.5
1.23
0.88
nmol/l
0.72
15
130
10
64
1.57
0.58
1.8
2.1
20.50
8.76
umol/l
—
10
45
10
64
1.57
0.58
2.6
2.2
—
—
—
0
0
24
184
1.31
0.58
1.1
1.2
—
—
—
0
0
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
14
195
0.71
0.56
1.6
1.5
—
—
—
0
0
734
7200
1.10
0.54
4.6
4.3
1.39
1.47
mmol/l
5.13
663
6591
26
320
0.81
0.46
1.8
1.9
—
—
—
0
0
16
121
1.33
0.44
1.6
1.6
—
—
—
0
0
5
31
1.62
0.43
3.2
2.2
64.40
44.36
umol/l
—
5
25
5
34
1.47
0.40
1.0
2.3
—
—
—
0
0
5
35
1.43
0.39
11.8
3.6
209.20
213.57
u/l
—
5
35
6
47
1.28
0.32
2.0
1.4
91.00
83.15
umol/l
—
6
47
10
132
0.75
0.32
2.2
1.7
—
—
—
0
0
8
63
1.27
0.28
1.5
1.3
—
—
—
0
0
8
67
1.20
0.26
1.3
1.5
—
—
—
0
0
12
95
1.27
0.26
2.3
1.3
—
—
—
0
0
12
95
1.27
0.26
2.3
1.3
—
—
—
0
0
12
95
1.27
0.26
2.2
1.3
—
—
—
0
0
12
96
1.25
0.24
2.3
1.3
—
—
—
0
0
40
360
1.12
0.24
2.3
2.9
47.97
60.52
u/ml
0.24
40
347
12
97
1.24
0.23
2.3
1.3
—
—
—
0
0
12
97
1.24
0.23
2.3
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
16
188
0.85
0.21
2.3
1.8
33.81
38.56
nmol/l
0.46
16
176
56
520
1.08
0.19
2.8
2.2
12.91
13.14
nmol/l
0.06
45
462
105
999
1.06
0.19
1.5
1.4
—
—
—
0
0
17
195
0.87
0.17
1.4
1.4
—
—
—
0
0
240
2339
1.04
0.16
4.6
5.0
2.33
2.91
ug/l
0.54
213
2092
182
1876
0.96
0.16
3.9
4.2
21.66
21.23
%
0.13
82
890
90
926
0.97
0.08
13.2
6.7
—
—
—
0
0
32
338
0.94
0.08
1.0
1.0
—
—
—
0
0
6
73
0.82
0.07
1.0
1.6
—
—
—
0
0
10
92
1.09
0.03
1.6
1.6
—
—
—
0
0
135
1364
0.99
0.03
2.5
3.0
0.63
0.77
ug/l
1.28
96
878
24
248
0.97
0.02
1.7
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
0.67
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
20
200
1.00
-0.00
1.3
1.4
—
—
—
0
0
197
1970
1.00
-0.00
1.7
1.7
1.40
1.37
mmol/l
0.26
146
1665
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_VASCULITISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_VASCULITISNAS | 2.781 [2.39, 3.24] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.216 |
During the follow-up period (1.1.1998 — 31.12.2019), 1063 out of 2856 females with L12_VASCULITISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_VASCULITISNAS | 2.679 [2.22, 3.24] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 699 out of 1962 males with L12_VASCULITISNAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_VASCULITISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.272% | 0.627% |
| 5 | 1.768% | 3.441% |
| 10 | 4.143% | 8.225% |
| 15 | 8.192% | 15.612% |
| 20 | 13.626% | 25.911% |
Relationships between endpoints
↥Index endpoint: L12_VASCULITISNAS – Other and unspecified vasculitis limited to skin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data